2020
DOI: 10.3390/s20092713
|View full text |Cite
|
Sign up to set email alerts
|

Wearable Solutions for Patients with Parkinson’s Disease and Neurocognitive Disorder: A Systematic Review

Abstract: Prevalence of neurocognitive diseases in adult patients demands the use of wearable devices to transform the future of mental health. Recent development in wearable technology proclaimed its use in diagnosis, rehabilitation, assessment, and monitoring. This systematic review presents the state of the art of wearables used by Parkinson’s disease (PD) patients or the patients who are going through a neurocognitive disorder. This article is based on PRISMA guidelines, and the literature is searched between Januar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
71
0
8

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 93 publications
(79 citation statements)
references
References 49 publications
0
71
0
8
Order By: Relevance
“…Wearable sensors are now influencing healthcare and medicine by allowing remote health monitoring, analysis of the healthcare condition, and prediction of health events [ 22 ]. Wearables, as well as health apps, have grown in popularity in recent years [ 23 ] Besides monitoring physical exercise, heart rate, sleep, or calories, they are also able to support the management of chronically ill patients suffering from specific diseases such as Parkinson’s disease, neurocognitive disorders, or diabetes [ 24 ].…”
Section: Introductionmentioning
confidence: 99%
“…Wearable sensors are now influencing healthcare and medicine by allowing remote health monitoring, analysis of the healthcare condition, and prediction of health events [ 22 ]. Wearables, as well as health apps, have grown in popularity in recent years [ 23 ] Besides monitoring physical exercise, heart rate, sleep, or calories, they are also able to support the management of chronically ill patients suffering from specific diseases such as Parkinson’s disease, neurocognitive disorders, or diabetes [ 24 ].…”
Section: Introductionmentioning
confidence: 99%
“…A total of 18 subjects with PD were recruited from different Parkinson associations located in Spain and Portugal who were in early stages (≤2) of the disease according to the Hoehn and Yahr (H&Y) scale [ 79 ] (age: 64.9 ± 7.6 [ 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 ] years; gender: 8 M/10 F; stage H&Y I/II/: 4/14). Patients had a good clinical response to levodopa and/or dopamine agonists and did not present dementia according to the diagnostic and statistical manual of mental disorders IV (DSM IV) criteria [ 78 ].…”
Section: Methodsmentioning
confidence: 99%
“…Many studies are focused on the development and validation of systems for the analysis and quantification of motor symptoms remotely using a variety of inertial sensors. The most commonly used sensors include accelerometers and gyroscopes due to their compact size and affordability [ 65 , 66 , 67 , 68 , 69 , 70 ].…”
Section: Introductionmentioning
confidence: 99%
“…Wearable sensors, accelerometers, gyroscopes, and non-wearable devices have been tested as ambulatory devices to assess motor parameters such as gait, kinematic features, sway, physical activity, tremor, and bradykinesia ( 49 , 50 ). These technologies can result in safe, objective, real-time behavioral assessments in clinical routine and facilitate the identification of care problems with more time dedicated to developing management plans and provide patient education during a clinical encounter.…”
Section: Integration Of Technology In Pd Care: Potential Challengesmentioning
confidence: 99%